Loading...

RGNX REGENXBIO INC Investments/Divestments 8-K Filing

RGNX

RGNX

REGENXBIO INC

(RGNX)

2023 8-K

Settlement Agreement

Financial Results Announced

FDA Response Letter

FDA Holds Trials

Financial Results Report

FDA Date Extension

Debt-Equity Swaps

Financial Statements

Financial Results

Collaboration Agreement

Collaboration Agreement

Financial Results

Management Grant of Restric...

Earnings Reports

Management Change

Annual Meeting Voting Results

Earnings Reports

Underwriting Agreement

Financial Results Press Rel...

Earnings Reports

Equity Offering

Earnings Reports

Annual Meeting Voting Results

Earnings Reports

Financial Results Press Rel...

Management Changes

External Links:

REGENXBIO Inc. entered into an ATM Equity OfferingSM Sales Agreement with BofA Securities, Inc. to offer and sell its common stock up to $150.0 million.

AI Assistant

REGENXBIO INC

2023

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.